Cases 101 - 110 of 15,352
Cassidy v. Boehringer Ingelheim Pharmaceuticals, Inc.
as 23-880
Plaintiff / Appellee:
Mary Cassidy
Defendant / Appellant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Vazzano v. Boehringer Ingelheim Pharmaceuticals, Inc.
as 23-882
Plaintiff / Appellee:
Thomas Vazzano
Defendant / Appellant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Araghi v. GlaxoSmithKline LLC et al
as 9:2023cv80953
Plaintiff:
Shahin Araghi
Defendant:
GlaxoSmithkline LLC, Sanofi-Aventis U.S. LLC, Chattem Inc. and others
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal-Product Liability
Feiler v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 9:2023cv80956
Defendant:
GSK, PLC, Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi S.A. and others
Plaintiff:
Rebecca M. Feiler
Cause Of Action: 28 U.S.C. § 1332 Diversity-Petition for Removal
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00715
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Defendant:
Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd., Shaghai Anovent Pharmaceutical Co., Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Anobri Pharmaceuticals US, LLC et al
as 1:2023cv00716
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH
Defendant:
Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd. and Shanghai Anovent Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
RICHARTZ et al v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al
as 2:2023cv03584
Plaintiff:
PAUL RICHARTZ and LINDA RICHARTZ
Defendant:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. ANOBRI PHARMACEUTICALS US, LLC et al
as 2:2023cv03530
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
ANOBRI PHARMACEUTICALS US, LLC, NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. and SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Apotex Inc. et al
as 1:2023cv00685
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Moates v. Boehringer Ingelheim Corporation et al
as 3:2023cv20574
Plaintiff:
Jerry Moates and James Moates
Defendant:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
